What is Regeneron Pharmaceuticals's net change in cash?

Regeneron Pharmaceuticals (REGN) reported net change in cash of -$153.1M in Q1 2026.

How has Regeneron Pharmaceuticals's net change in cash changed year-over-year?

Regeneron Pharmaceuticals's net change in cash decreased by 125.3% year-over-year, from $604M to -$153.1M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Regeneron Pharmaceuticals REGN Net Change in Cash

Net Change in Cash at other companies

Merck & Co.MRK

-$9.29B-103%

AmgenAMGN

$2.91B+192%

Nektar TherapeuticsNKTR

$134.46M+2,610%

GlaukosGKOS

$13.44M+124%

EyePoint, Inc. EYPT

-$24.11M-65.7%

PrecigenPGEN

-$22.75M+3.0%

Other financials

Income statement

See full

Revenue$3.6B+19.0%

Operating income$642.9M+8.7%

Net income$727.2M-10.1%

EPS (diluted)$6.75-7.2%

Balance sheet

See full

Cash & equivalents$3.0B-4.0%

Total debt$2.7B+0.1%

Total equity$31.4B+6.9%

Total assets$40.9B+8.9%

Cash flow

See full

Operating cash flow$1.1B+3.2%

CapEx$230.6M+0.6%

Free cash flow$848.3M+4.0%

Valuation

See full

Market cap$66.35B+17.7%

Enterprise value$66.09B+15.8%

P/E15×+2.4×

P/S4.5×+0.5×

Profitability

See full

Gross margin93.9%—

Operating margin24.3%-2.9pp

Net margin29.6%-2.3pp

FCF margin27.6%+5.5pp

Returns & leverage

See full

Return on equity14.5%-1.4pp

Debt / equity0.1×0.0×

Current ratio3.6×-1.4×

Where this comes from

Reported directly by Regeneron Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regeneron Pharmaceuticals's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regeneron Pharmaceuticals's net change in cash?: Regeneron Pharmaceuticals (REGN) reported net change in cash of -$153.1M in Q1 2026.
How has Regeneron Pharmaceuticals's net change in cash changed year-over-year?: Regeneron Pharmaceuticals's net change in cash decreased by 125.3% year-over-year, from $604M to -$153.1M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.